The Convention on Biological Diversity (CBD), often referred to as the Biodiversity Convention, is a groundbreaking legally binding international treaty that fundamentally changed how the world manages natural resources.
The entire legal and operational architecture of the CBD revolves around three inseparable goals:
-
The Conservation of Biological Diversity: Protecting ecosystems, wild habitats, and species both in their natural environments (in situ) and in specialized research facilities (ex situ).
-
The Sustainable Use of its Components: Ensuring that humanity can continue to utilize biological resources (forestry, agriculture, tourism) without causing their long-term decline.
-
The Fair and Equitable Sharing of Benefits: Guaranteeing that any commercial or scientific profits arising from the use of genetic resources—especially in biotechnology and medicine—are shared fairly with the countries and indigenous communities where those resources originated.
The convention serves as an umbrella framework that has birthed major international legal protocols and milestones to address emerging ecological challenges:
-
The Cartagena Protocol on Biosafety (2000): Regulates the transboundary movement, handling, and use of Living Modified Organisms (LMOs) resulting from modern biotechnology, protecting natural biodiversity from potential risks.
-
The Nagoya Protocol (2010): A critical legal mechanism that enforces the third goal of the convention. It sets up strict rules on Access and Benefit-Sharing (ABS), preventing “biopiracy” by ensuring multinational corporations pay fair royalties to developing nations when developing drugs or products from local plants.
-
The Kunming-Montreal Global Biodiversity Framework (GBF): Adopted globally to guide conservation efforts through 2030, this landmark pact establishes the famous “30x30 target”—a binding commitment by world governments to protect at least 30% of the planet’s land, inland waters, and oceans by the end of the decade.